Chronic Heart Failure — clinical cases
29 questions
Sample cases
- Case 1
A 64-year-old man is diagnosed with heart failure with reduced ejection fraction (LVEF 30%, NYHA class II) after an echocardiogram. He takes furosemide 40 mg daily. BP 124/76 mmHg, heart rate 82 bpm, eGFR 68 mL/min/1.73 m², potassium 4.2 mmol/L (4.2 mEq/L). Which combination represents the foundational disease-modifying therapy that should be built for him?
- A.Sacubitril/valsartan, bisoprolol, spironolactone and dapagliflozin
- B.Ramipril, candesartan, bisoprolol and digoxin
- C.Sacubitril/valsartan, ivabradine, digoxin and hydralazine
- D.Ramipril, amlodipine, atenolol and dapagliflozin
- Case 2
A 70-year-old woman with HFrEF (LVEF 28%) takes enalapril 10 mg twice daily, metoprolol succinate 100 mg daily, spironolactone 25 mg daily and empagliflozin 10 mg daily. She took her last enalapril dose at 08:00 today. Her cardiologist switches her to sacubitril/valsartan 49/51 mg twice daily. When is the earliest she should take the first dose of sacubitril/valsartan?
- A.At 20:00 today, in place of her next scheduled enalapril dose
- B.Tomorrow at 08:00, 24 hours after the last enalapril dose
- C.At 20:00 tomorrow, at least 36 hours after the last enalapril dose
- D.After a 7-day enalapril-free washout period
- Case 3
A 58-year-old man with newly diagnosed HFrEF (LVEF 32%) had angioedema of the lips and tongue 4 years ago while taking lisinopril for hypertension. He now takes carvedilol, spironolactone, dapagliflozin and furosemide. BP 128/78 mmHg, eGFR 72 mL/min/1.73 m², potassium 4.3 mmol/L (4.3 mEq/L). Which renin-angiotensin system agent is most appropriate to add?
- A.Sacubitril/valsartan 24/26 mg twice daily
- B.Candesartan 4 mg once daily, with close monitoring
- C.Ramipril 1.25 mg once daily, with close monitoring
- D.Sacubitril/valsartan after a 36-hour washout
